Dare Bioscience (DARE)
(Delayed Data from NSDQ)
$0.45 USD
+0.01 (3.31%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $0.45 0.00 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
Dare Bioscience, Inc. [DARE]
Reports for Purchase
Showing records 141 - 160 ( 214 total )
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
4Q19 - On the Lookout for Partnership Opportunities in 2020
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Reports 2019, Raises Modest Capital, Watching Timelines
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
We are sending out a reminder about our 33rd Annual Conference
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Two Women''s Health Companies to See - Why at Our 32nd Conference
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Yas'' Weekly Recap of Our Key Notes and 11 Doc Calls Upcoming in 1H20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways from Our Ovaprene and BV1 Expert Call with Dr. Andrea Thurman
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Join Our Call Today to Find Out What Made Bayer Fall in Love with Ovaprene
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Yas'' Weekly Recap of Our Key Notes and 12 Doc Calls Upcoming in 1H20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Yas'' Weekly Recap of Our Key Notes and 9 Doc Calls Upcoming in 1Q20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Join Our Feb. 3 Call to Find Out What Made Bayer Fall in Love with Ovaprene
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Yas'' Weekly Recap of Our Key Notes
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Part 3: "Must-See" Companies at JPM (Mkt. Cap. <$100M) With 1Q20 Catalysts
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Yas'' Weekly Recap of Our Key Notes
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare-Expert Call Recap for 2019 in Women''s Health
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Yas'' Weekly Recap of Our Key Notes and Upcoming Events
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y